Our Services
Medical Information
Helpful Resources
Published on: 5/13/2026
HLA-DQB1*06:02 testing can help clarify a narcolepsy type 1 diagnosis if you have excessive daytime sleepiness, cataplexy, or sleep paralysis. To prepare, track your sleep and symptoms for a week or two, gather your personal and family medical history, and write down focused questions before your visit.
See below for comprehensive details on when testing is helpful, how to discuss it with your doctor, what to expect during the testing process, how to interpret results, and appropriate follow-up steps based on your outcome.
If you're exploring Narcolepsy genetic testing 2026 as part of understanding unexplained daytime sleepiness or other narcolepsy symptoms, asking your doctor about an HLA-DQB1*06:02 test can be an important step. Below is a clear, straightforward guide to help you prepare for that conversation and understand what comes next.
Consider requesting this test if you experience:
If you're still uncertain about your symptoms, try this free Medically approved LLM Symptom Checker Chat Bot to help you better describe your concerns before your visit.
Keep a simple log for 1–2 weeks noting:
Gather information on:
Write down key questions such as:
Having this list will keep the conversation focused and efficient.
When you meet your doctor, you can use language like:
"I've been reading about Narcolepsy genetic testing 2026 and the role of the HLA-DQB1*06:02 gene variant. Given my symptoms of [briefly describe], would it make sense to test for this marker?"
Or:
"I'd like to discuss whether HLA-DQB1*06:02 testing could help clarify what's causing my daytime sleepiness."
These simple, direct statements show you've done your homework and invites your doctor to give a detailed response.
Ask your doctor to explain exactly how results fit into your overall diagnostic picture.
Narcolepsy genetic testing 2026 is evolving. Even if your first test or visit doesn't give a definitive answer, ongoing communication with your doctor is key. Share new symptoms promptly and revisit testing if recommended.
If you experience any of the following, seek medical attention right away:
For less urgent concerns, consider using this Medically approved LLM Symptom Checker Chat Bot to organize your symptoms and determine the right time to contact your doctor.
Always speak to a qualified healthcare professional about any symptoms that could be serious or life threatening. Your doctor is your best resource for personalized advice and treatment plans.
(References)
* Mignot E, Lammers GJ, Ripley B, et al. HLA-DQB1*06:02 typing for narcolepsy diagnosis. Neurology. 2001 Jul 10;57(1):151-2. PMID: 11445700.
* Han F, Mignot E. Diagnostic utility of HLA DQB1*06:02 typing for narcolepsy. Semin Neurol. 2004 Dec;24(4):375-82. PMID: 15614920.
* Dauvilliers Y, Arnulf I, Mignot E. Clinical utility of HLA-DQB1*06:02 typing in the diagnosis of narcolepsy type 1. Sleep Med. 2011 Dec;12 Suppl 2:S18-21. PMID: 22177375.
* Lunsford NL, Dauvilliers Y. Narcolepsy Type 1 Diagnosis in the Context of HLA-DQB1*06:02: A Comprehensive Review. Curr Neurol Neurosci Rep. 2017 Jul;17(7):52. PMID: 28500446.
* Zhang C, Han F. The Role of HLA-DQB1*06:02 in Narcolepsy Type 1 and Its Genetic and Environmental Associations. J Sleep Res. 2021 Oct;30(5):e13352. PMID: 33759247.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.